Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological Analysis

Area of Science:

• Immunology
• Endocrinology
• Reproductive Biology

Background:

• Gestational diabetes mellitus (GDM) is a common pregnancy disorder linked to inflammation.
• The underlying molecular mechanisms of GDM, particularly immune system involvement, require further elucidation.
• Galectin-2 is known to modulate immune cell activity.

Purpose of the Study:

• To investigate galectin-2 expression in placentas from GDM patients and controls.
• To analyze expression in a sex-specific manner.
• To characterize the cell types expressing galectin-2 in GDM placentas.

Main Methods:

• Placental tissue samples from 40 GDM patients and 40 controls were analyzed.
• Immunohistochemistry was employed for semi-quantitative expression analysis.
• Double immunofluorescence was used to identify galectin-2 expressing cell phenotypes.

Main Results:

• Galectin-2 was significantly upregulated in the syncytiotrophoblast and decidua of GDM placentas.
• Strong galectin-2 expression was observed in extra-villous trophoblast cells and fetal endothelial cells in GDM.
• This represents the first systematic investigation of galectin-2 in GDM.

Conclusions:

• Galectin-2 is upregulated in the placenta during gestational diabetes mellitus.
• These findings contribute to understanding GDM's inflammatory pathways and galectin-2's role.
• The results may have implications for the long-term cardiovascular health of offspring affected by GDM.